Person

Maria C. Freire

Director, Biogen

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$1.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 29, 2022ARESale289$164.59$48K
Jul 28, 2022ARESale2,311$163.04$377K
Feb 14, 2020ARESale1,465$174.20$255K
Aug 16, 2018ARESale3,000$128.67$386K
May 4, 2017ARESale2,174$113.30$246K

SEC reporting-owner ID (CIK) 1547999 · all filings on EDGAR

Maria C. Freire (BIIB, ARE) | USBoard